Bextra, or valdecoxib, is an anti-inflammatory drug used to treat symptoms of osteoarthritis and rheumatoid arthritis and to relieve painful menstrual cramps. Pfizer voluntarily withdrew Bextra from the market in 2005, after use of Bextra was shown to increase the risk of cardiovascular events, including heart attack and stroke. Bextra has also been linked to Stevens-Johnson syndrome, a sometimes fatal skin disease. SJS causes painful blistering and erosion of skin, rashes, and selling of skin and mucous membranes.
Pfizer Respectfully Disagrees with FDA Decision on Bextra
In April 2005, the Federal Drug & Food Administration (FDA) asked Pfizer Inc. to suspend sales of Bextra. Bextra is in the same class of drugs as Merck & Co's drug Vioxx, the COX-2 inhibitor pain reliever whose withdrawal from the market in September 2004 started the analysis of patient signals that Vioxx, like Bextra, caused increased rates of heart attacks and strokes in some people who took the medication.
read more
Bextra Still Off the Market
Bextra®, generic name Valdecoxib, is a prescription COX-2 selective non-steroidal anti-inflammatory drug (NSAID) manufactured by Pfizer, Inc . On April 7, 2005, the Federal Drug & Food Administration (FDA) asked Pfizer to suspend sales of Bextra and to withdraw the drug from all markets due to adverse Bextra side effects. The FDA convened a public advisory committee meeting in February 2005 to review the cardiovascular safety of all COX-2 inhibitors and related drugs.
read more
View the Bextra Law Articles page here
Bextra Jury Verdicts
______ $526,801 remitted to $369,507. Breakdown: $225,000 for pain and suffering; $34,702 for past medicals; $5,385 for past wage loss; $261,714 for future medicals; and $0 for future wage loss. - Soft Tissue Crush Injuries Yield $526,801 Verdict
______ VERDICT - MEDICAL MALPRACTICE - ALLEGED FAILURE TO PROPERLY MONITOR BLEED TIMES AFTER PRESCRIBING COUMADIN - INTERCRANIAL BLEED - WRONGFUL DEATH AT AGE 81.
View the
Bextra Jury Verdicts
page here
Bextra Videos
Information about Bextra Lawsuits
View the
Bextra Videos
page here
Bextra FDA Information
CDER NME Approvals in Calendar Year 2001
Alert for Healthcare Professionals: Valdecoxib (marketed as Bextra)
View the
Bextra FDA Information
page here
Bextra News Articles
Glenmark Plans New Type Of Pain Killers
¹ú¼ÊÒ©Æó¹«²¼Ö§¸¶¸øÒ½ÉúµÄ¾ßÌ屨³ê-ÉúÎïÒ½Ò©²úÒµ - ÉúÎï¹È
View the
Bextra News Articles
page here
Bextra Newsfeeds
Inhibitex completes INX-189 Phase1a trial for HCV
NSAIDs Interfere With Tissue Healing
View the
Bextra Newsfeeds
page here
Bextra Patents
Substituted isoxazoles for the treatment of inflammation
View the
Bextra Patents
page here
Bextra Useful Web Sites
James F. Humphreys, LC, Bextra
Anapol Schwartz, Bextra Attorneys
View the
Bextra Useful Web Sites
page here
Bextra Wikipedia
Valdecoxib
Osteoarthritis
View the
Bextra Wikipedia
page here